Home

av Sloka Tjudra teva products for asthma Ambassadör profil Korkad

Teva Pharmaceuticals Axes Phase 2 Asthma Trial
Teva Pharmaceuticals Axes Phase 2 Asthma Trial

Buying Proair HFA Generic Salbutamol - Asthma Inhalers from Canada
Buying Proair HFA Generic Salbutamol - Asthma Inhalers from Canada

Teva's DuoResp Spiromax wins silver at MDEA
Teva's DuoResp Spiromax wins silver at MDEA

Teva Canada Announces Availability of Aermony RespiClick™, an Innovative  New Device for the Treatment of Bronchial Asthma | BioSpace
Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | BioSpace

Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round |  Fierce Pharma
Perrigo, Catalent get generic of Teva inhaler approved on 4th go-round | Fierce Pharma

Teva launches connected inhaler for asthma, COPD - Drug Delivery Business
Teva launches connected inhaler for asthma, COPD - Drug Delivery Business

Teva's Respiratory Drugs Contribute 11% to Specialty Medicines
Teva's Respiratory Drugs Contribute 11% to Specialty Medicines

Buy Proair HFA Online – Salbutamol Canada
Buy Proair HFA Online – Salbutamol Canada

Generic Salbutamol Inhaler 100 mcg/200 dose - Canada Generic Pharmacy
Generic Salbutamol Inhaler 100 mcg/200 dose - Canada Generic Pharmacy

Teva Pharmaceutical Industries Ltd | Access to Medicine Foundation
Teva Pharmaceutical Industries Ltd | Access to Medicine Foundation

AstraZeneca's new asthma drug to take on GSK, Teva and Novartis after  clearing clinical hurdles
AstraZeneca's new asthma drug to take on GSK, Teva and Novartis after clearing clinical hurdles

Teva's Asthma Segment: What Could Boost Its Revenues in 2016?
Teva's Asthma Segment: What Could Boost Its Revenues in 2016?

Teva introduces QVAR RediHaler inhalation aerosol in US - Pharmaceutical  Technology
Teva introduces QVAR RediHaler inhalation aerosol in US - Pharmaceutical Technology

Teva | Contract Pharma
Teva | Contract Pharma

Teva Canada commercialises Aermony RespiClick for bronchial asthma
Teva Canada commercialises Aermony RespiClick for bronchial asthma

Teva's Digihaler linked to improved asthma control in trial
Teva's Digihaler linked to improved asthma control in trial

Phil and Teva Pharmaceuticals Launch New Program to Improve Access to the  Digihaler® Family of Inhalers to Support Asthma Management | Business Wire
Phil and Teva Pharmaceuticals Launch New Program to Improve Access to the Digihaler® Family of Inhalers to Support Asthma Management | Business Wire

Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma  Treatment - Drug Discovery and Development
Teva Introduces Inhalation Powder and Generic Version in U.S. for Asthma Treatment - Drug Discovery and Development

Teva Breathes Its Way to a Guinness World Records Title in Recognition of  World Asthma Day
Teva Breathes Its Way to a Guinness World Records Title in Recognition of World Asthma Day

Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma  Medication | Asthma and Allergy Foundation of America
Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America

Teva Pharmaceuticals buys smart inhaler company Gecko Health Innovations |  MobiHealthNews
Teva Pharmaceuticals buys smart inhaler company Gecko Health Innovations | MobiHealthNews

Teva and Biolojic Design Announce Exclusive License Agreement for the  Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma
Teva and Biolojic Design Announce Exclusive License Agreement for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma

Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler®  (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir®  Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire

Teva Pharmaceuticals on LinkedIn: #ers #ers2022 #tevapharm #respiratory  #asthmaawareness #copdawareness
Teva Pharmaceuticals on LinkedIn: #ers #ers2022 #tevapharm #respiratory #asthmaawareness #copdawareness

FDA Approves Teva's ProAir Digihaler for Asthma, COPD | RT
FDA Approves Teva's ProAir Digihaler for Asthma, COPD | RT

Teva Pharmaceuticals Europe
Teva Pharmaceuticals Europe